References
1. Patel SY, Carbone J, Jolles S. The expanding field of secondary antibody deficiency: causes, diagnosis, and management. Frontiers in immunology. 2019;10:33.
2. Jolles S, Borrell R, Zouwail S, et al. Calculated globulin (CG) as a screening test for antibody deficiency. Clinical & Experimental Immunology. 2014;177(3):671-678.
3. Wood PM. Primary antibody deficiency syndromes. Current opinion in hematology. 2010;17(4):356-361.
4. Bousfiha A, Jeddane L, Picard C, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification.Journal of clinical immunology. 2020;40(1):66-81.
5. Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. The Journal of Allergy and Clinical Immunology: In Practice.2016;4(1):38-59.
6. Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Current opinion in allergy and clinical immunology. 2012;12(6):595-601.
7. Dhalla F, Misbah SA. Secondary antibody deficiencies. Current opinion in allergy and clinical immunology. 2015;15(6):505-513.
8. Pecoraro A, Jolles S, Crescenzi L, et al. Validation of calculated globulin (CG) as a screening test for antibody deficiency in an Italian university hospital. Current Pharmaceutical Biotechnology.2018;19(9):728-733.
9. Piza CFSdT, Aranda CS, Solé D, Jolles S, Condino-Neto A. Serum protein electrophoresis may be used as a screening tool for antibody deficiency in children and adolescents. Frontiers in Immunology.2021;12:712637.
10. Youden WJ. Index for rating diagnostic tests. Cancer.1950;3(1):32-35.
11. Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochemia medica. 2016;26(3):297-307.
12. Wilson JMG, Jungner G, Organization WH. Principles and practice of screening for disease. 1968.
13. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. Cmaj. 2018;190(14):E422-E429.
14. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Annals of Allergy, Asthma & Immunology. 2007;99(3):281-283.
15. O’Connell T, Horita TJ, Kasravi B. Understanding and interpreting the serum protein electrophoresis. American family physician.2005;71(1):105-112.
16. Ogryzlo M, Maclachlan M, Dauphinee J, Fletcher A. The serum proteins in health and disease: filter paper electrophoresis. The American Journal of Medicine. 1959;27(4):596-616.
17. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc . 2001;76(5):476-487.
18. Quinti I, Spadaro G, Jolles S, Condino-Neto A. The complexity of primary antibody deficiencies. Frontiers in immunology.2021;12:635482.
19. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades.Blood, The Journal of the American Society of Hematology.2012;119(7):1650-1657.
20. Graziano V, Pecoraro A, Mormile I, et al. Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels. Clinical Immunology. 2017;180:1-4.
Table 1: Distribution of the clinics, patient diagnosis and concomitant treatment according to IgG levels